Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

5:35 PM - 5:55 PM PT

Question and Answers
Speaker: Refaat, Tamer, MD, PhD, MS - Loyola University Chicago, Chicago, Illinois
5:40 PM - 5:50 PM PT

272 - A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer
Speaker: Farrugia, Mark, MD, PhD - Roswell Park Cancer Institute, Buffalo, NY
5:40 PM - 5:50 PM PT

277 - Feasibility, Safety and Patient Reported Early Clinical Outcomes of Spatially Fractionated Radiotherapy of Unresectable Bulky Tumors Followed by SBRT Delivery
Speaker: Pokhrel, Damodar, PhD - UK Kentucky, Markey Comprehensive Cancer Center, Lexington, KY
5:40 PM - 5:50 PM PT

Discussant
Speaker: McCormick, Beryl, MD, FASTRO - Memorial Sloan Kettering Cancer Center, Middletown, NY
5:40 PM - 5:50 PM PT

Discussant
Speaker: Tang, Chad, MD - MD Anderson Cancer Center, Houston, TX
5:50 PM - 6:00 PM PT

278 - Low Radiation Doses to Peripheral Tumor Tissue in Metabolism Guided Lattice Irradiation Based on LATTICE-01 Study: A Search for Dose Constraints to Determine a "Spatial Analysis of Peripherical Tissue Effects in the Clinic (SpatialP-TEC)"
Speaker: Ferrantelli, Giacomo, MD - University of Messina, Messina, Sicilia
5:50 PM - 6:00 PM PT

Discussant
Speaker: Chang, Joe, MD, PhD, MS, FASTRO - MD Anderson Cancer Center, Houston, TX
5:55 PM - 6:00 PM PT

Closing
Speaker: Dyer, Brandon, MD - Legacy Health System-Good Samaritan Hospital, Portland , OR
5:55 PM - 6:00 PM PT

Closing
Speaker: Jhingran, Anuja, MD, BS, FASTRO - MD Anderson Cancer Center, Houston, TX

Tuesday, September 30

8:00 AM - 8:10 AM PT

279 - Utilization of a Lumpectomy Bed Boost after Whole Breast Radiotherapy Does Not Improve Ipsilateral Breast Tumor Recurrence Risk in Patients with Ductal Carcinoma In-Situ Treated on Three NSABP Trials
Speaker: Khan, Atif, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
8:00 AM - 8:10 AM PT

284 - Cognitive Function and Quality of Life in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II Study
Speaker: Slater, Jason, MD - Department of Radiation Medicine, Loma Linda University, Loma Linda, CA
8:00 AM - 8:10 AM PT

289 - Sequential Chemo-Immunotherapy as a Novel Bridging Strategy for Non-Complete Responders after Neoadjuvant Chemoradiotherapy in Esophageal Cancer: First Prospective Phase 2 Trial Challenging Immediate Surgery Paradigm
Speaker: Wang, Qifeng, MD - Sichuan Cancer Hospital and Institute, Chengdu, Sichuan